Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
Details for Australian Patent Application No. 2005205531 (hide)
International Classifications
Event Publications
27 July 2006 PCT application entered the National Phase
PCT publication WO2005/068461 Priority application(s): WO2005/068461
31 August 2006 Amendment Made
The nature of the amendment is: Add co-inventor Druzgala, Pascal and Rubens, Courtney
17 March 2011 Application Accepted
Published as AU-B-2005205531
14 July 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005205533-M-CSF-specific monoclonal antibody and uses thereof
2005205527-Catalyst compositions and polyolefins for extrusion coating applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser